Cargando…

PMON243 Metabolic Disorders Genetically Modify Polycystic Ovary Syndrome through its Candidate Hormones

INTRODUCTION: As the most common endocrine disorder in reproductive-aged women, polycystic ovary syndrome (PCOS) increases the risk of developing several cardiometabolic disorders like insulin resistance. However, Mendelian randomization (MR) studies provide little support for direct causal associat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Actkins, Ky’Era, Davis, Lea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627338/ http://dx.doi.org/10.1210/jendso/bvac150.1434

Ejemplares similares

Genetic Sex Effects of Polycystic Ovary Syndrome Reveal Distinct Metabolic Etiology
por: Actkins, Ky’Era, et al.
Publicado: (2021)

SAT-024 Investigating Racial and Ethnic Comorbidity Patterns of Polycystic Ovary Syndrome
por: Actkins, Ky’Era, et al.
Publicado: (2020)

Sex modifies the effect of genetic risk scores for polycystic ovary syndrome on metabolic phenotypes
por: Actkins, Ky’Era V., et al.
Publicado: (2023)

Characterizing the Clinical and Genetic Spectrum of Polycystic Ovary Syndrome in Electronic Health Records
por: Actkins, Ky’Era V, et al.
Publicado: (2020)

PMON208 METFORMIN, SPIRONOLACTONE AND ORAL CONTRACEPTIVES IN POLYCYSTIC OVARY SYNDROME: A NETWORK META-ANALYSIS
por: Rodriguez-Gutierrez, Rene, et al.
Publicado: (2022)

PMON245 Clinical Phenotypes of Polycystic Ovary Syndrome (PCOS) in Nigerian Women: Preliminary Results of the Nigeria PCOS Epidemiology & Phenotype (Nigeria-Pep) Study
por: Balogun, Mobolanle, et al.
Publicado: (2022)

PMON219 Disparities in Musculoskeletal Health Profiles Across Race and Ethnicity in United States-Based Women with Polycystic Ovary Syndrome per the 2018 International Guideline
por: Kazemi, Maryam, et al.
Publicado: (2022)

PMON220 Women With Polycystic Ovary Syndrome Have Worse Lifestyle Behaviors Compared to Controls: A Systematic Review and Meta-Analysis of 36,360 Women
por: Ganga, Kiran, et al.
Publicado: (2022)

PMON244 Alterations in Nonesterified Free Fatty Acids (NEFA) Trafficking Rather Than Hyperandrogenism Contribute to Variations in Insulin Sensitivity Among Obese Women with Polycystic Ovary Syndrome
por: Azziz, Ricardo, et al.
Publicado: (2022)

RF10 | PMON249 MicroRNA-21 Ablation Exacerbates Androgen-Mediated White Adipose Tissue Dysfunction and Impaired Insulin Signaling in a Mouse Model of Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2022)

FRI457 Protein-coding Genetic Variation In Polycystic Ovary Syndrome
por: Parker, Chloe, et al.
Publicado: (2023)

RF34 | PMON222 Reproductive Hormone Secretion is Increased by Intranasal Kisspeptin in Humans
por: Mills, Edouard G, et al.
Publicado: (2022)

PMON280 Effect of Gender Affirming Hormone Therapy (GAHT) on Adipose Tissue Morphology and Metabolism in Transgender Individuals
por: Shah, Manasi S, et al.
Publicado: (2022)

PMON211 Energy metabolism hormones irisin and leptin affect steroidogenesis in human granulosa cells: in vitro studies
por: Avtanski, Dimiter, et al.
Publicado: (2022)

FRI426 Raised Thyroid Stimulating Hormone In Girls With Polycystic Ovary SyndromeEffects Of Randomized Interventions
por: Ibanez, Lourdes, et al.
Publicado: (2023)

RF34 | PMON202 The Human Metabolic Profile of Estetrol
por: Gérard, Céline, et al.
Publicado: (2022)

OR35-04 Anti-Müllerian Hormone Variants identified in Patients with Polycystic Ovary Syndrome Affect Secretion and Immunoactivity
por: Meng, Li, et al.
Publicado: (2023)

Polycystic Ovary Syndrome as Metabolic Disease: New Insights on Insulin Resistance
por: Genazzani, Alessandro D, et al.
Publicado: (2023)

MON-233 Effect of Weight Loss and Hormonal Suppression Alone and in Combination on Bioactive Gut and Ovarian Peptide Hormones in Women with Polycystic Ovary Syndrome
por: Legro, Richard, et al.
Publicado: (2019)

A Genetically Defined Male Counterpart of Polycystic Ovary Syndrome: Evidence for Ovarian-Independent Pathogenesis
por: Zhu, Jia, et al.
Publicado: (2021)

PMON209 Ceramides Predict Metabolic Response to Metformin in Women with PCOS
por: Sharma, Anu, et al.
Publicado: (2022)

RF34 | PMON203 Copy Number Variant Analysis Reveals Novel Candidate Genes Associated with Primary Ovarian Insufficiency
por: Franca, Monica, et al.
Publicado: (2022)

OR35-03 Uncovering Causative Mutations in Polycystic Ovary Syndrome
por: Srivastava, Jaya, et al.
Publicado: (2023)

FRI409 Childbirth Experiences In Women With Polycystic Ovary Syndrome
por: Husby, Anne Engtrø, et al.
Publicado: (2023)

The Calcium-Sensing Receptor (CaSR) Variants at rs1801725 Increase the Risk of Developing Secondary Malignant Cancers
por: Beasley, Heather K, et al.
Publicado: (2021)

ODP642 Differences in hormonal profiles and vitamin D status depending on the insulin sensitivity status in women with polycystic ovary syndrome (PCOS).
por: Ozga-Piszczek, Katarzyna, et al.
Publicado: (2022)

SUN-019 Androgens Modulate Lipid Metabolism and Absorption in Control and Polycystic Ovary-Metabolic Syndrome Conditions
por: Vine, Donna Faye, et al.
Publicado: (2020)

PMON246 Prevalence of Hypertension and Metabolic Syndrome in Women with PCOS from France and Brazil
por: Spritzer, Poli Mara, et al.
Publicado: (2022)

THU636 Prevalence Of Metabolic Syndrome In A Sample Of Hispanic Patients With Polycystic Ovary Syndrome
por: Arroyo, Isabel C, et al.
Publicado: (2023)

PMON260 Cost-Effectiveness of Testosterone Treatment for Men with Hypogonadism
por: Jayasena, Channa, et al.
Publicado: (2022)

MON-205 Is Muscle Mechanical Function Altered In Polycystic Ovary Syndrome?
por: Caliskan Guzelce, Ezgi, et al.
Publicado: (2019)

SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
por: Parveen, Sanober, et al.
Publicado: (2019)

SUN-018 No Difference in Breastfeeding Rates in Women with Polycystic Ovary Syndrome
por: Bui, Leeann, et al.
Publicado: (2020)

OR35-06 Polycystic Ovary Syndrome Is Associated With an Increased Mortality Risk
por: Ollila, Meri-Maija, et al.
Publicado: (2023)

SUN-021 Age-Specific Multiples of the Median Level of Serum Anti-Mullerian Hormone Is a Potential Marker for Diagnosis of Polycystic Ovary Syndrome
por: Raymond Li, Hang Wun, et al.
Publicado: (2020)

MON-215 Comparison of Ultrasonographic and Biochemical Markers of Polycystic Ovarian Morphology Across the Phenotypic Spectrum of Polycystic Ovary Syndrome
por: Jarrett, Brittany, et al.
Publicado: (2019)

THU635 Metabolic Characteristics Among Polycystic Ovary Syndrome-Phenotypes In A Sample Of Hispanic Patients
por: Gonzalez-Rodriguez, Loida Alejandra, et al.
Publicado: (2023)

OR15-5 Cognitive Function in Reproductive Aged Individuals with Polycystic Ovary Syndrome
por: Cedars, Marcelle, et al.
Publicado: (2022)

SAT370 Economic Burden of Endometrial Cancer Associated with Polycystic Ovary Syndrome
por: Pace, Lauren Arielle, et al.
Publicado: (2023)

PMON275 GONAD-on-CHIP to study early gonad development and DSD
por: Bashamboo, Anu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qq58ksnqjrcotp0tm6j12iorql